Chang Min, Li Wei, Peng Ya-li, Gao Ya-hu, Yao Jia, Han Ren-wen, Wang Rui
Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Sciences, State Key Laboratory of Applied Organic Chemistry, Lanzhou University, Lanzhou 730000, PR China.
Brain Res. 2009 May 19;1271:36-48. doi: 10.1016/j.brainres.2009.03.041. Epub 2009 Mar 28.
The mas-related genes (Mrgs, also known as sensory neuron-specific receptors, SNSRs) are specifically expressed in small diameter sensory neurons in the trigeminal and dorsal root ganglia, suggesting an important role of the receptors in pain transmission. The present study aimed to investigate the underlying mechanism of the nociceptive effects after activation of MrgC, and the interaction between MrgC and N/OFQ-NOP receptor system in modulation of nociception in mice. Intrathecal (i.t.) administration of [Tyr(6)] gamma2-MSH(6-12), the most potent agonist for MrgC receptor, produced a significant hyperalgesic response as assayed by tail withdrawal test and a series of characteristic nociceptive responses, including biting, licking and scratching, in a dose-dependent manner (0.01-10 pmol and 0.01-10 nmol, respectively) in mice. These pronociceptive effects induced by [Tyr(6)] gamma2-MSH(6-12) were inhibited dose-dependently by co-injection of competitive NMDA receptor antagonist D-APV, non-competitive NMDA receptor antagonist MK-801, and nitric oxide (NO) synthase inhibitor L-NAME. However, the tachykinin NK(1) receptor antagonist L-703,606, and tachykinin NK(2) receptor antagonist MEN-10,376, had no influence on pronociceptive effects elicited by [Tyr(6)] gamma2-MSH(6-12). In other groups, [Tyr(6)] gamma2-MSH(6-12)-induced nociceptive responses were bidirectionally regulated by the co-injection of N/OFQ. N/OFQ inhibited nociceptive responses at high doses (0.01-1 nmol), but potentiated the behaviors at low doses (1 fmol-3 pmol). Furthermore, both hyperalgesia and nociceptive responses were enhanced after the co-administration with NOP receptor antagonist [Nphe(1)]N/OFQ(1-13)-NH(2). These results suggest that intrathecal [Tyr(6)] gamma2-MSH(6-12)-induced pronociceptive effects may be mediated through NMDA receptor-NO system in the spinal cord, and demonstrate the interaction between MrgC and N/OFQ-NOP receptor system in pain transmission.
与mas相关的基因(Mrgs,也称为感觉神经元特异性受体,SNSRs)在三叉神经节和背根神经节的小直径感觉神经元中特异性表达,表明这些受体在疼痛传递中起重要作用。本研究旨在探讨MrgC激活后伤害性效应的潜在机制,以及MrgC与N/OFQ-NOP受体系统在调节小鼠伤害感受中的相互作用。鞘内注射[Tyr(6)]γ2-MSH(6-12),MrgC受体最有效的激动剂,通过甩尾试验检测,在小鼠中产生了显著的痛觉过敏反应,并伴有一系列特征性的伤害性反应,包括咬、舔和抓挠,呈剂量依赖性(分别为0.01-10 pmol和0.01-10 nmol)。[Tyr(6)]γ2-MSH(6-12)诱导的这些促伤害性效应被竞争性NMDA受体拮抗剂D-APV、非竞争性NMDA受体拮抗剂MK-801和一氧化氮(NO)合酶抑制剂L-NAME的共注射剂量依赖性抑制。然而,速激肽NK(1)受体拮抗剂L-703,606和速激肽NK(2)受体拮抗剂MEN-10,376对[Tyr(6)]γ2-MSH(6-12)引起的促伤害性效应没有影响。在其他组中,[Tyr(6)]γ2-MSH(6-12)诱导的伤害性反应受到N/OFQ共注射的双向调节。N/OFQ在高剂量(0.01-1 nmol)时抑制伤害性反应,但在低剂量(1 fmol-3 pmol)时增强行为。此外,与NOP受体拮抗剂[Nphe(1)]N/OFQ(1-13)-NH(2)共同给药后,痛觉过敏和伤害性反应均增强。这些结果表明,鞘内注射[Tyr(6)]γ2-MSH(6-12)诱导的促伤害性效应可能通过脊髓中的NMDA受体-NO系统介导,并证明了MrgC与N/OFQ-NOP受体系统在疼痛传递中的相互作用。